Literature DB >> 12655643

The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome.

Susann Schweiger1, Rainer Schneider.   

Abstract

Opitz BBB/G syndrome is a monogenic disorder that is characterized by malformations of the ventral midline. Investigations into the underlying genetic defects and the pathobiochemistry of this syndrome have already shed light on the mechanisms of both the physiological and the pathological development of the ventral midline, a complicated multistep process. Moreover, these studies have revealed the ubiquitin-dependent regulation of microtubule-associated phosphatase 2A, a central mechanism in many cellular processes. In this review, we summarize recent findings and speculate upon their implications for both medical and general research. Copyright 2003 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12655643     DOI: 10.1002/bies.10256

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  27 in total

1.  Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).

Authors:  Beatriz Aranda-Orgillés; Désirée Rutschow; Raphael Zeller; Antonios I Karagiannidis; Andrea Köhler; Changwei Chen; Timothy Wilson; Sven Krause; Stefan Roepcke; David Lilley; Rainer Schneider; Susann Schweiger
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Structural and functional insights into the B30.2/SPRY domain.

Authors:  Jae-Sung Woo; Joon-Hyuk Imm; Chang-Ki Min; Kyung-Jin Kim; Sun-Shin Cha; Byung-Ha Oh
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

3.  Control of mTORC1 signaling by the Opitz syndrome protein MID1.

Authors:  Enbo Liu; Christine A Knutzen; Sybille Krauss; Susann Schweiger; Gary G Chiang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

4.  The phosphatase subunit tap42 functions independently of target of rapamycin to regulate cell division and survival in Drosophila.

Authors:  Katherine D Cygnar; Xinsheng Gao; Duojia Pan; Thomas P Neufeld
Journal:  Genetics       Date:  2005-03-31       Impact factor: 4.562

5.  The E3 ubiquitin ligase- and protein phosphatase 2A (PP2A)-binding domains of the Alpha4 protein are both required for Alpha4 to inhibit PP2A degradation.

Authors:  Michele LeNoue-Newton; Guy R Watkins; Ping Zou; Katherine L Germane; Lisa R McCorvey; Brian E Wadzinski; Benjamin W Spiller
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

6.  The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.

Authors:  Haijuan Du; Yongzhao Huang; Manar Zaghlula; Erica Walters; Timothy C Cox; Michael A Massiah
Journal:  J Biol Chem       Date:  2013-06-05       Impact factor: 5.157

7.  Csf2 null mutation alters placental gene expression and trophoblast glycogen cell and giant cell abundance in mice.

Authors:  Amanda N Sferruzzi-Perri; Anne M Macpherson; Claire T Roberts; Sarah A Robertson
Journal:  Biol Reprod       Date:  2009-02-18       Impact factor: 4.285

8.  A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction.

Authors:  Felipe Diaz-Griffero; Xu-rong Qin; Fumiaki Hayashi; Takanori Kigawa; Andres Finzi; Zoe Sarnak; Maritza Lienlaf; Shigeyuki Yokoyama; Joseph Sodroski
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

Review 9.  TRIM family proteins and their emerging roles in innate immunity.

Authors:  Keiko Ozato; Dong-Mi Shin; Tsung-Hsien Chang; Herbert C Morse
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

10.  Two Novel Pathogenic MID1 Variants and Genotype-Phenotype Correlation Reanalysis in X-Linked Opitz G/BBB Syndrome.

Authors:  Nuno Maia; Maria J Nabais Sá; Nataliya Tkachenko; Gabriela Soares; Isabel Marques; Bárbara Rodrigues; Ana M Fortuna; Rosário Santos; Arjan P M de Brouwer; Paula Jorge
Journal:  Mol Syndromol       Date:  2017-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.